| PERIOD ENDING | 31-Mar-09 | 31-Dec-08 | 30-Sep-08 | 30-Jun-08 | | Total Revenue | 2,914,268 | 3,678,394 | 3,481,074 | 4,570,472 | | Cost of Revenue | 1,983,400 | 2,412,454 | 2,215,450 | 2,946,725 | | | Gross Profit | 930,868 | 1,265,940 | 1,265,624 | 1,623,747 | | | Operating Expenses | | Research Development |
-
|
-
|
-
|
-
| | Selling General and Administrative | 732,739 | 800,213 | 669,967 | 822,435 | | Non Recurring | 89,997 |
-
| (98,590) |
-
| | Others | 50,570 | 51,614 | 46,797 | 44,600 | | | | Total Operating Expenses |
-
|
-
|
-
|
-
| | | | Operating Income or Loss | 57,562 | 414,113 | 647,450 | 756,712 | | | Income from Continuing Operations | | Total Other Income/Expenses Net | (3,692) | (14,457) | 17,224 | 24,233 | | Earnings Before Interest And Taxes | 53,870 | 399,656 | 664,674 | 780,945 | | Interest Expense | 31,298 | 40,346 | 38,063 | 36,575 | | Income Before Tax | 22,572 | 359,310 | 626,611 | 744,370 | | Income Tax Expense | 52,000 | 86,000 | 146,500 | 215,900 | | Minority Interest |
-
|
-
|
-
|
-
| | | | Net Income From Continuing Ops | (29,428) | 273,310 | 480,111 | 528,470 | | | Non-recurring Events | | Discontinued Operations | (9,946) | (39,536) | (26,593) | (380) | | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | (39,374) | 233,774 | 453,518 | 528,090 | | Preferred Stock And Other Adjustments |
-
|
-
|
-
|
-
| | | Net Income Applicable To Common Shares | ($39,374) | $233,774 | $453,518 | $528,090 |
|
0.45% Nasdaq 
0.20%
Income Statement
